|
ANKRD40 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.079800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.493800E-01 |
| Normal-vs-Stage2 |
8.400200E-01 |
| Normal-vs-Stage3 |
5.414400E-01 |
| Normal-vs-Stage4 |
9.416800E-01 |
| Stage1-vs-Stage2 |
8.418800E-01 |
| Stage1-vs-Stage3 |
5.833200E-01 |
| Stage1-vs-Stage4 |
9.284000E-01 |
| Stage2-vs-Stage3 |
7.876400E-01 |
| Stage2-vs-Stage4 |
9.554800E-01 |
| Stage3-vs-Stage4 |
7.867600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.285200E-01 |
| Normal-vs-AfricanAmerican |
8.167800E-01 |
| Normal-vs-Asian |
7.813400E-01 |
| Caucasian-vs-AfricanAmerican |
3.222600E-01 |
| Caucasian-vs-Asian |
6.406000E-01 |
| AfricanAmerican-vs-Asian |
8.399200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.197000E-01 |
| Normal-vs-Female |
2.703800E-02 |
| Male-vs-Female |
1.326210E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.503200E-01 |
| Normal-vs-Extreme_Weight |
9.431000E-01 |
| Normal-vs-Obese |
3.127400E-01 |
| Normal-vs-Extreme_Obese |
4.473400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.246800E-01 |
| Normal_Weight-vs-Obese |
1.192640E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.532800E-01 |
| Extreme_Weight-vs-Obese |
4.468800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.494400E-01 |
| Obese-vs-Extreme_Obese |
2.724400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.919400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.428200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.508200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.101700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.626180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.303800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.764400E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.717200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.155530E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.529230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.022150E-01 |
| Normal-VS-Type2 PRCC |
2.256800E-01 |
| Normal-VS-KIRP CIMP |
1.685560E-01 |
| Normal-VS-Unclassified PRCC |
3.720800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.967890E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.235600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.925200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.285600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.662200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.851600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.522800E-01 |
| Normal-vs-N1 |
1.959440E-01 |
| Normal-vs-N2 |
2.431600E-01 |
| N0-vs-N1 |
4.626200E-02 |
| N0-vs-N2 |
1.502420E-02 |
| N1-vs-N2 |
2.626400E-01 |
|
|
